Schedule 13D ownership disclosure

Orthofix Medical Inc

Common stock, $0.10 par value per share · CUSIP: 68752M108

Event date: 2024-12-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Juniper Targeted Opportunity Fund, L.P.Reported CIK 0001524397

    Shares: 1,554,725.00 · Class: 4.1%

  • Juniper HF Investors II, LLC

    Shares: 1,554,725.00 · Class: 4.1%

  • Juniper Targeted Opportunities, L.P.Reported CIK 0001680619

    Shares: 356,024.00 · Class: 0.9%

  • Juniper Targeted Opportunity Investors, LLC

    Shares: 356,024.00 · Class: 0.9%

  • Juniper Multi-Strategy Fund, L.P.

    Shares: 26,500.00 · Class: 0.1%

  • Juniper HF Investors, LLC

    Shares: 26,500.00 · Class: 0.1%

  • Juniper Investment Company, LLCReported CIK 0001794034

    Shares: 1,937,249.00 · Class: 5.1%

  • Alexis P. MichasReported CIK 0001044005

    Shares: 1,937,249.00 · Class: 5.1%

  • John A. BartholdsonReported CIK 0001382909

    Shares: 1,937,249.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-000281
Form type
SCHEDULE 13D
Filer
Juniper Investment Company, LLC
CIK
CIK 1794034
Filed
Jan 07, 2025
Reporting period
Dec 30, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub